MedTrace Logo

Phase II Study of Pallidotomy for Parkinson Disease

NCT00004670 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES:

I. Evaluate the safety and efficacy of pallidotomy immediately following 3 preoperative assessments vs. delayed pallidotomy following 6 months of standard medical therapy in patients with Parkinson disease.

Conditions

  • Parkinson Disease

Interventions

PROCEDURE

pallidotomy

Sponsors & Collaborators

  • Emory University

    collaborator OTHER

  • National Center for Research Resources (NCRR)

    lead NIH

Principal Investigators

  • Mahlon R. DeLong · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004670 on ClinicalTrials.gov